These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7105593

  • 21. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.
    Arabia G, Zappia M, Bosco D, Crescibene L, Bagalà A, Bastone L, Caracciolo M, Scornaienghi M, Quattrone A.
    Neurol Sci; 2002 Sep; 23 Suppl 2():S53-4. PubMed ID: 12548340
    [Abstract] [Full Text] [Related]

  • 22. Apomorphine and diphasic dyskinesia.
    Durif F, Deffond D, Dordain G, Tournilhac M.
    Clin Neuropharmacol; 1994 Feb; 17(1):99-102. PubMed ID: 8149366
    [Abstract] [Full Text] [Related]

  • 23. [Motor complications in Parkinson disease, in patients undergoing levodopa therapy].
    García de Yébenes J, García Urra D, Vázquez A.
    Neurologia; 1989 Feb; 4(1):1-3. PubMed ID: 2631800
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease.
    Fox S, Silverdale M, Kellett M, Davies R, Steiger M, Fletcher N, Crossman A, Brotchie J.
    Mov Disord; 2004 May; 19(5):554-60. PubMed ID: 15133820
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Parkinson's disease in 1984: an update.
    Lang AE, Blair RD.
    Can Med Assoc J; 1984 Nov 01; 131(9):1031-7. PubMed ID: 6388779
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical aspects of motor fluctuations in Parkinson's disease.
    Poewe WH.
    Neurology; 1994 Jul 01; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
    [Abstract] [Full Text] [Related]

  • 34. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M.
    J Clin Neurosci; 2009 Aug 01; 16(8):1034-7. PubMed ID: 19428256
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
    Rascol O.
    Mov Disord; 1999 Aug 01; 14 Suppl 1():19-32. PubMed ID: 10493400
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
    Strong JA, Dalvi A, Revilla FJ, Sahay A, Samaha FJ, Welge JA, Gong J, Gartner M, Yue X, Yu L.
    Mov Disord; 2006 May 01; 21(5):654-9. PubMed ID: 16435402
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.